← The SEC Ephemeris: the whole map
LIB Therapeutics, Inc. Lerochol
In the graph: all 1 documents (2 pages).
- Application
- BLA 761427
- Ticker
- LIB Therapeutics, Inc.
- Product
- Lerochol
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- December 12, 2025
From FDA letters and SEC filings. Not investment or medical advice.